Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 41 studies | 35% ± 14% | |
| fibroblast | 35 studies | 30% ± 14% | |
| pericyte | 32 studies | 34% ± 13% | |
| smooth muscle cell | 25 studies | 34% ± 11% | |
| endothelial cell of lymphatic vessel | 20 studies | 34% ± 12% | |
| macrophage | 19 studies | 28% ± 10% | |
| oligodendrocyte | 14 studies | 40% ± 16% | |
| myofibroblast cell | 14 studies | 33% ± 17% | |
| capillary endothelial cell | 13 studies | 29% ± 8% | |
| epithelial cell | 13 studies | 38% ± 21% | |
| connective tissue cell | 12 studies | 36% ± 13% | |
| glutamatergic neuron | 10 studies | 42% ± 18% | |
| monocyte | 10 studies | 24% ± 7% | |
| neuron | 10 studies | 51% ± 18% | |
| vein endothelial cell | 10 studies | 27% ± 8% | |
| astrocyte | 10 studies | 34% ± 14% | |
| conventional dendritic cell | 9 studies | 24% ± 7% | |
| endothelial cell of vascular tree | 9 studies | 27% ± 7% | |
| type I pneumocyte | 8 studies | 29% ± 7% | |
| classical monocyte | 8 studies | 23% ± 6% | |
| non-classical monocyte | 8 studies | 22% ± 6% | |
| endothelial cell of artery | 8 studies | 32% ± 9% | |
| goblet cell | 8 studies | 29% ± 16% | |
| basal cell | 8 studies | 40% ± 17% | |
| ciliated cell | 8 studies | 40% ± 16% | |
| mast cell | 7 studies | 22% ± 5% | |
| natural killer cell | 7 studies | 22% ± 8% | |
| mesothelial cell | 7 studies | 33% ± 15% | |
| GABAergic neuron | 7 studies | 39% ± 17% | |
| microglial cell | 7 studies | 32% ± 9% | |
| oligodendrocyte precursor cell | 7 studies | 30% ± 11% | |
| myeloid cell | 7 studies | 25% ± 12% | |
| leukocyte | 6 studies | 19% ± 5% | |
| abnormal cell | 6 studies | 28% ± 14% | |
| interneuron | 6 studies | 51% ± 20% | |
| retinal ganglion cell | 6 studies | 71% ± 20% | |
| amacrine cell | 6 studies | 35% ± 16% | |
| retinal rod cell | 6 studies | 35% ± 16% | |
| alveolar macrophage | 5 studies | 19% ± 5% | |
| B cell | 5 studies | 23% ± 8% | |
| epithelial cell of proximal tubule | 5 studies | 27% ± 9% | |
| kidney loop of Henle epithelial cell | 5 studies | 27% ± 6% | |
| progenitor cell | 5 studies | 28% ± 14% | |
| T cell | 5 studies | 23% ± 11% | |
| transit amplifying cell | 5 studies | 25% ± 16% | |
| glial cell | 5 studies | 30% ± 18% | |
| retina horizontal cell | 5 studies | 35% ± 14% | |
| retinal cone cell | 5 studies | 37% ± 20% | |
| adipocyte | 5 studies | 23% ± 9% | |
| dendritic cell | 5 studies | 28% ± 11% | |
| regulatory T cell | 5 studies | 23% ± 7% | |
| secretory cell | 5 studies | 29% ± 15% | |
| CD4-positive, alpha-beta T cell | 4 studies | 21% ± 5% | |
| brush cell | 4 studies | 35% ± 17% | |
| club cell | 4 studies | 32% ± 13% | |
| mononuclear phagocyte | 4 studies | 26% ± 10% | |
| lymphocyte | 4 studies | 30% ± 10% | |
| Mueller cell | 4 studies | 27% ± 6% | |
| OFF-bipolar cell | 4 studies | 33% ± 24% | |
| ON-bipolar cell | 4 studies | 33% ± 24% | |
| enteroendocrine cell | 4 studies | 33% ± 15% | |
| pancreatic A cell | 3 studies | 39% ± 16% | |
| naive B cell | 3 studies | 19% ± 2% | |
| hematopoietic precursor cell | 3 studies | 25% ± 7% | |
| glomerular endothelial cell | 3 studies | 40% ± 6% | |
| kidney distal convoluted tubule epithelial cell | 3 studies | 38% ± 9% | |
| mature NK T cell | 3 studies | 19% ± 4% | |
| neural crest cell | 3 studies | 32% ± 5% | |
| retinal bipolar neuron | 3 studies | 33% ± 13% | |
| granule cell | 3 studies | 28% ± 5% | |
| precursor B cell | 3 studies | 23% ± 9% | |
| GABAergic amacrine cell | 3 studies | 27% ± 2% | |
| glycinergic amacrine cell | 3 studies | 23% ± 4% | |
| rod bipolar cell | 3 studies | 26% ± 3% | |
| CD8-positive, alpha-beta T cell | 3 studies | 22% ± 2% | |
| innate lymphoid cell | 3 studies | 24% ± 6% | |
| erythroblast | 3 studies | 36% ± 22% | |
| luminal hormone-sensing cell of mammary gland | 3 studies | 31% ± 5% | |
| pancreatic ductal cell | 3 studies | 50% ± 23% | |
| enterocyte | 3 studies | 18% ± 3% | |
| respiratory goblet cell | 3 studies | 26% ± 11% | |
| plasmacytoid dendritic cell | 3 studies | 25% ± 8% | |
| hepatocyte | 3 studies | 39% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 17 studies | 35% ± 17% | |
| lung | 11 studies | 35% ± 16% | |
| eye | 10 studies | 31% ± 13% | |
| intestine | 7 studies | 28% ± 13% | |
| kidney | 6 studies | 27% ± 9% | |
| peripheral blood | 5 studies | 22% ± 4% | |
| liver | 5 studies | 34% ± 21% | |
| heart | 4 studies | 19% ± 4% | |
| uterus | 4 studies | 33% ± 13% | |
| pancreas | 3 studies | 40% ± 19% | |
| placenta | 3 studies | 19% ± 2% | |
| breast | 3 studies | 21% ± 2% | |
| adipose | 3 studies | 23% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 5707.67 | 1445 / 1445 | 100% | 54.35 | 183 / 183 |
| ovary | 100% | 4950.07 | 180 / 180 | 100% | 38.37 | 430 / 430 |
| stomach | 100% | 3821.57 | 359 / 359 | 100% | 45.19 | 286 / 286 |
| breast | 100% | 5572.11 | 459 / 459 | 100% | 69.92 | 1117 / 1118 |
| lung | 100% | 4588.69 | 577 / 578 | 100% | 45.43 | 1155 / 1155 |
| brain | 100% | 5378.27 | 2641 / 2642 | 100% | 72.52 | 704 / 705 |
| intestine | 100% | 5489.33 | 966 / 966 | 100% | 44.48 | 526 / 527 |
| prostate | 100% | 3854.98 | 245 / 245 | 100% | 42.44 | 500 / 502 |
| bladder | 100% | 5741.76 | 21 / 21 | 99% | 40.48 | 500 / 504 |
| uterus | 100% | 6206.26 | 170 / 170 | 99% | 41.00 | 455 / 459 |
| thymus | 100% | 4187.87 | 652 / 653 | 99% | 48.77 | 599 / 605 |
| kidney | 100% | 3899.65 | 89 / 89 | 99% | 47.80 | 889 / 901 |
| skin | 100% | 5751.35 | 1808 / 1809 | 99% | 44.22 | 465 / 472 |
| adrenal gland | 100% | 4598.86 | 258 / 258 | 95% | 35.74 | 219 / 230 |
| pancreas | 96% | 2388.29 | 316 / 328 | 98% | 44.17 | 175 / 178 |
| liver | 74% | 1062.50 | 167 / 226 | 85% | 19.39 | 347 / 406 |
| adipose | 100% | 5707.89 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 7303.35 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3049.74 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 36.32 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 15.64 | 1 / 1 |
| muscle | 100% | 3015.26 | 801 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 23.65 | 28 / 29 |
| heart | 97% | 3204.15 | 831 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 90% | 24.35 | 72 / 80 |
| peripheral blood | 67% | 1777.36 | 621 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007018 | Biological process | microtubule-based movement |
| GO_0010970 | Biological process | transport along microtubule |
| GO_0005813 | Cellular component | centrosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005868 | Cellular component | cytoplasmic dynein complex |
| GO_0031982 | Cellular component | vesicle |
| GO_0030286 | Cellular component | dynein complex |
| GO_0005874 | Cellular component | microtubule |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0045504 | Molecular function | dynein heavy chain binding |
| GO_0045503 | Molecular function | dynein light chain binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003777 | Molecular function | microtubule motor activity |
| Gene name | DYNC1I2 |
| Protein name | Dynein cytoplasmic 1 intermediate chain 2 Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2) |
| Synonyms | DNCI2 DNCIC2 |
| Description | FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function . Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules . The intermediate chains mediate the binding of dynein to dynactin via its 150 kDa component (p150-glued) DCTN1 (By similarity). Involved in membrane-transport, such as Golgi apparatus, late endosomes and lysosomes (By similarity). . |
| Accessions | E7ERH4 ENST00000412370.5 ENST00000422646.1 ENST00000709741.1 [Q13409-5] Q13409 E7EU01 ENST00000709732.1 [Q13409-7] ENST00000452242.5 E7ESD3 ENST00000435234.5 ENST00000438879.5 ENST00000423910.5 ENST00000709731.1 [Q13409-1] ENST00000709735.1 [Q13409-6] ENST00000709730.1 [Q13409-3] ENST00000445378.5 ENST00000397119.8 [Q13409-1] ENST00000409197.5 [Q13409-3] E7EV09 ENST00000508530.5 [Q13409-6] ENST00000340296.8 [Q13409-3] E7ERR6 ENST00000409773.5 [Q13409-1] E7EUM4 ENST00000411953.5 ENST00000430778.5 ENST00000410079.7 [Q13409-7] ENST00000709738.1 [Q13409-2] E7EQL5 ENST00000409317.5 [Q13409-2] ENST00000409453.5 [Q13409-5] ENST00000456808.5 ENST00000709736.1 [Q13409-3] E7EMU4 ENST00000443458.5 E7ETL8 ENST00000425485.5 ENST00000709739.1 [Q13409-1] E9PGG1 E7EQU2 E7ET01 |